Literature DB >> 26102439

EFFECT OF INTERNAL LIMITING MEMBRANE PEELING ON LONG-TERM VISUAL OUTCOMES FOR DIABETIC MACULAR EDEMA.

Kazuyuki Kumagai1, Masanori Hangai, Nobuchika Ogino, Eric Larson.   

Abstract

PURPOSE: To evaluate the effect of internal limiting membrane (ILM) peeling on the long-term visual outcomes in eyes with diffuse, nontractional diabetic macular edema.
METHODS: One hundred and sixteen eyes of 58 patients with the same degree of diabetic macular edema in both eyes underwent pars plana vitrectomy with the creation of a posterior vitreous detachment in both eyes. Internal limiting membrane peeling was performed in one randomly selected eye (ILM-off group), and ILM peeling was not performed (ILM-on group) in the fellow eye. The postoperative follow-up period ranged from 12 months to 161 months (average, 80.4 months).
RESULTS: In the ILM-off group, the mean best-corrected visual acuity in logMAR units (Snellen equivalent) increased from 0.55 ± 0.31 (20/71) before surgery to 0.35 ± 0.35 (20/45) at 1 year (P < 0.0001) and 0.46 ± 0.43 (20/59) at the final visit (P = 0.058). In the ILM-on group, the mean best-corrected visual acuity increased from 0.55 ± 0.41 (20/71) before surgery to 0.43 ± 0.38 (20/54) at 1 year (P = 0.010) and 0.44 ± 0.45 (20/56) at the final visit (P = 0.043). The differences in the best-corrected visual acuity between the two groups were not significant at any time point.
CONCLUSION: Pars plana vitrectomy with or without ILM peeling improves the long-term visual acuity of nontractional diabetic macular edema. Internal limiting membrane peeling does not affect the postoperative best-corrected visual acuity significantly.

Entities:  

Mesh:

Year:  2015        PMID: 26102439     DOI: 10.1097/IAE.0000000000000497

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  9 in total

1.  Efficacy and safety of vitrectomy with internal limiting membrane peeling for diabetic macular edema: a Meta-analysis.

Authors:  Xin-Ying Hu; Huan Liu; Li-Na Wang; Yu-Zhi Ding; Jie Luan
Journal:  Int J Ophthalmol       Date:  2018-11-18       Impact factor: 1.779

Review 2.  ILM peeling in nontractional diabetic macular edema: review and metanalysis.

Authors:  M Rinaldi; R dell'Omo; F Morescalchi; F Semeraro; E Gambicorti; F Cacciatore; F Chiosi; C Costagliola
Journal:  Int Ophthalmol       Date:  2017-10-31       Impact factor: 2.031

Review 3.  Management of diabetic macular edema in Japan: a review and expert opinion.

Authors:  Hiroko Terasaki; Yuichiro Ogura; Shigehiko Kitano; Taiji Sakamoto; Toshinori Murata; Akito Hirakata; Tatsuro Ishibashi
Journal:  Jpn J Ophthalmol       Date:  2017-12-05       Impact factor: 2.447

4.  Authors' reply.

Authors:  Seemant Raizada; Jamal Al Kandari; Fahad Al Diab; Khalid Al Sabah; Niranjan Kumar; Sebastian Mathew
Journal:  Indian J Ophthalmol       Date:  2015-10       Impact factor: 1.848

5.  Vitrectomy for center-involved diabetic macular edema.

Authors:  David J Browning; Chong Lee; Michael W Stewart; Maurice B Landers
Journal:  Clin Ophthalmol       Date:  2016-04-26

Review 6.  Surgical Versus Medical Treatment for Diabetic Macular Edema: A Review.

Authors:  Nicolás Crim; Raúl Velez-Montoya; Virgilio Morales-Canton
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2017

Review 7.  The Evolving Treatment of Diabetic Retinopathy.

Authors:  Sam E Mansour; David J Browning; Keye Wong; Harry W Flynn; Abdhish R Bhavsar
Journal:  Clin Ophthalmol       Date:  2020-03-04

8.  Pars Plana Vitrectomy with Internal Limiting Membrane Peeling for Nontractional Diabetic Macular Edema.

Authors:  Jan Niklas Ulrich
Journal:  Open Ophthalmol J       Date:  2017-01-31

9.  Outcomes of 25-Gauge Vitrectomy for Tractional and Nontractional Diabetic Macular Edema with Proliferative Diabetic Retinopathy.

Authors:  Hideaki Someya; Kei Takayama; Masaru Takeuchi; Hiroshi Yokoyama; Takeshi Kimura; Masakazu Morioka; Yoshihiro Takamura; Seiji Sameshima; Tetsuo Ueda; Nahoko Ogata; Maki Tashiro; Shigehiko Kitano; Taiji Sakamoto
Journal:  J Ophthalmol       Date:  2019-12-11       Impact factor: 1.909

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.